View profile

THCB Reader - Issue #10

Revue
 
Today’s edition of THCB reader includes: Ken Terry pointing out the FTC’s little involvement in large
 

THCB Reader

June 13 · Issue #10 · View online
Everything you always wanted to know about the health care system. But were afraid to ask.

Today’s edition of THCB reader includes: Ken Terry pointing out the FTC’s little involvement in large hospital mergers and how Medicare’s expansion programs may slow down the consolidation and impact the space on its own; André Blackman arguing the need for a diverse and inclusive health care force to drive innovation and growth in the space; and Luke Oakden-Rayner explaining why one of the best papers in AI Research has been largely ignored by the industry. On video, THCB Spotlights Chris Gervais, who told me about Kyruus’s work in coordinating patient demand with physician supply for large health systems, and Jess & I report from HIMSS Health 2.0 in Europe for the latest episode of Health in 2 Point 00. Matthew Holt

June 13, Ken Terry
Much of the growth in health spending can be attributed to industry consolidation. The Federal Trade Commission (FTC) has tried to stop very few hospital mergers and, as health economist Paul Ginsburg has pointed out, federal antitrust policy doesn’t directly address hospital acquisitions of physician practices. However, the Medicare for All and Medicare expansion proposals create a new space for countering industry consolidation—if anything should come from these ideas.

June 12, André Blackman
Diversity and inclusion is a hot topic to discuss these days, but in the health/health care landscape, it absolutely cannot just stop there. We’re not dealing strictly with products here — there are actual lives at stake. How we hire, retain, and advance the talented individuals from underrepresented communities (women, people of color, LGBTQ, disabled) is the only way we will see widespread, effective innovation across the industry.

June 7, Luke Oakden-Rayner
Our typical methods of testing AI systems are inadequate and potentially unsafe—all of the headline-grabbing papers so far only do controlled experiments, so we are unaware of how the AI systems will perform on real patients. But one study actually went all the way: a company called Shanghai Wision AI Co. produced a system that detects polyps in the bowel wall during a colonoscopy and did a real clinical trial. But why has this paper been (for the most part) ignored?
Livongo is working to #SilenceNoisyHealthcare. Visit livongo.com for more details.
THCB Spotlight | Chris Gervais, CTO of Kyruus
THCB Spotlight | Chris Gervais, CTO of Kyruus
Health in 2 Point 00, Episode 83 | Health 2.0 HIMSS Europe
Health in 2 Point 00, Episode 83 | Health 2.0 HIMSS Europe
We hope you enjoyed the pieces and videos we had for you today. As always, if you have a piece you would like us to consider, please email zoya@thehealthcareblog.com and if you are looking to reach 20K of the smartest people in health care on this newsletter, or 80-100K each month on the site, please think of sending some of your marketing $$$ our way! Here’s our prospectus.

Best Wishes,
Did you enjoy this issue?
If you don't want these updates anymore, please unsubscribe here
If you were forwarded this newsletter and you like it, you can subscribe here
Powered by Revue
120 Humboldt Avenue, San Anselmo, CA 94960